Trial Profile
A Multicenter open-labeled uncontrolled study in patients with Opioid-Induced Constipation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 30 Jun 2012 Methylnaltrexone bromide is still in phase II development in Japan, according to an Ono Pharmaceutical media release.
- 17 Nov 2010 New trial record